Companies: 10,795·Total market cap: $144.5T
Ainos, Inc.

Ainos, Inc.

AIMDNASDAQHealthcare● Active
$2.10
+$0.15(+7.69%)
Market Cap$9508275
P/E Ratio
52W High$4.5
52W Low$1.26

Ainos, Inc. (AIMD) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

aimd · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Ainos, Inc. (AIMD) measures how much investors pay for each dollar of the company's trailing earnings. AIMD's current PE ratio of N/A is calculated by dividing its stock price of $2.10 by its TTM earnings per share of -$2.31.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
EPS (TTM)
-$2.31
TTM · diluted EPS
PEG Ratio
-0.01
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Ainos, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2006 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 21.9x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Ainos, Inc.
Ainos, Inc.You
AIMD
$10MN/A-$2.31
Aditxt, Inc.
Aditxt, Inc.
ADTX
$0MN/A-$1116.70
Adlai Nortye Ltd.
Adlai Nortye Ltd.
ANL
$522MN/A-$3.33
Athira Pharma, Inc.
Athira Pharma, Inc.
ATHA
$27MN/A-$24.70
BioLineRx Ltd.
BioLineRx Ltd.
BLRX
$14MN/A-$0.29
Daré Bioscience, Inc.
Daré Bioscience, Inc.
DARE
$18MN/A-$0.12
FibroBiologics, Inc. Common Stock
FibroBiologics, Inc. Common Stock
FBLG
$2MN/A-$8.35

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-3.46
2024-12-31
FY2024
$-1.56
2023-12-31
FY2023
$-3.36
2022-12-31
FY2022
$-5.14
2021-12-31
FY2021
$-2.57
2020-12-31
FY2020
$-2.67
2019-12-31
FY2019
$-0.74
2018-12-31
FY2018
$-0.56
2017-12-31
FY2017
$-0.41
2016-12-31
FY2016
$-0.50

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Ainos, Inc. (AIMD) measures how much investors pay for each dollar of the company's trailing earnings. AIMD's current PE ratio of N/A is calculated by dividing its stock price of $2.10 by its TTM earnings per share of -$2.31.

PE Ratio = Stock Price ÷ EPS (TTM)
= $2.10 ÷ -$2.31 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

AIMD pe ratio · 6 questions

AIMD's current PE ratio is N/A as of 2026-06-08, based on a stock price of $2.10 and TTM EPS of -$2.31. Data sourced from Financial Modeling Prep via AIMD's SEC 10-K and 10-Q filings.

AIMD PE ratioWhat is AIMD PE ratioCurrent PE ratio of AIMDAIMD PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Ainos, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08